Zhao, Ting
Xu, Xiaolei
Wu, Yushan
Zhang, Wei
Zeng, Qin
Lu, Yanqiu
Yang, Tongtong
Zhou, Guoqiang
Yu, Jianhua
Lan, Ke
Harypursat, Vijay
Chen, Yaokai
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
https://doi.org/10.1186/s12879-022-07665-z
No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study
https://doi.org/10.1007/s40121-021-00586-5
Funding for this research was provided by:
The National Science and Technology Major Project of China during the 13th Five-year Plan period (2018ZX10302104)
Article History
Received: 5 April 2022
Accepted: 2 August 2022
First Online: 8 August 2022
Declarations
:
: The research was conducted in accordance with the Declaration of Helsinki. The study protocol was reviewed and approved by the Ethics Committee of Chongqing Public Health Medical Center (Approval Number: 2019-003-02-KY), and was duly registered as one of 12 trials under a general project at the Chinese Clinical Trial Registry (ChiCTR1900021195). Written informed consent was obtained from all the enrolled patients. All methods were carried out in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors have no conflicts of interest to declare. All co-authors have seen, read, and agree with the contents of the manuscript.